Introduction
Established evidence suggests an important role for viruses in the development of some human malignancies. These include Epstein-Barr virus in Bur, kitt's' and post-transplant lymphoma2 and human papillomavirus (HPV) types 16 and 18 in anogenital3 and cervical cancer. 4 Oncogenic HPV types may be involved in the development of skin cancer in patients with epidermodysplasia verruciformis (EV), a rare inherited condition predisposing to virus warts and skin cancer,5 and perhaps also in patients immunosuppressed following organ transplantation, but support for this remains controversial. The majority of skin cancers in the general population do not appear to be associated with HPV.
Human papillomaviruses
Papillomaviruses are small DNA viruses that infect both epidermal and mucosal squamous epithelia. Transmission is by direct contact (person to person or object to person) and is enhanced if the skin is broken or macerated. Approximately 60 HPV types have now been characterized, all ofwhich are trophic for squamous epithelia, although many show marked preference for one anatomical site over another. A small number of HPV types, including types 1, 2, 3, 4 and 10 typically infect keratinizing epithelia (the skin) and account for the majority of cutaneous warts in the general population. 6 Other rare epidermotrophic HPV types including 5, 8, 14, 17 and 207.8 have been identified in the skin of EV patients, but these types are rarely identified in the skin in the general population, even in immunosuppressed patients.9-" HPV types 6, 1 1, 16 and 18 are trophic for genital mucosa4 and are rarely identified in skin.
Papillomavirus replication occurs in fully differentiated keratinocytes and usually results in benign squamous proliferation (a papilloma). Transforming HPVs, which may be important in the development of some squamous cell carcinomas, include oncogenic types 5 and 8 (in the skin) and 16 and 18 (in genital mucosa).
Human papillomaviruses and cervical cancer
To date the most compelling evidence of a role for HPV is in the development of anogenital and cervical cancer. Oncogenic HPV types 16 and 18 are frequently identified in anogenital and cervical tumours whilst 'low-risk' HPV types 6 and 11 are more commonly associated with benign cervical lesions. 4 The oncogenicity of HPV 16 and 18 resides, at least in part, in the ability of viralencoded E6 and E7 proteins to bind and inactivate host tumour suppressor proteins (p53 and retinoblastoma, respectively).'2 HPV-encoded E6 and E7 sequences, critical for the transformation ofhuman keratinocytes in vitro,13 are specifically retained and expressed in cervical cell lines and genital tumours.'4"15 Inactivation of p53 tumour suppressor protein, in this case through binding to viral oncoproteins rather than gene mutation, appears to be a critical step in the development of diverse malignancies,'6 including anogenital and cervical carcinomas. 17, 18 Human papillomavirus and skin cancer Although in vitro studies'3 and animal models '9 suggest that skin cancers may be caused by HPV type 16 and 18 infection, this is not reflected in studies ofhuman skin cancer in the general population. For example, unlike cervical cancer where HPV types 16 or 18 are found in up to 90% of tumours, HPV 16 has consistently been identified only in peri-ungual squamous cell carcinomas. [20] [21] [22] [23] This is an unusual site for tumour development and probably reflects genital transmission of HPV 16 and 18.
HPV has been found in approximately 10% of skin cancers at other sites but, of these, no parti- with a role for HPV in the development of these tumours. EV is a rare condition, however, and studies are few. We need more research in these patients before a role for HPV can be fully established.
Organ transplant recipients
Organ transplant patients are a much larger cohort to study. They have a well-documented overall increased risk ofmalignancy,39 but an exceptionally high risk of developing virus-associated tumours including non-Hodgkin's lymphoma4' and cervical and anogenital carcinoma. 4 
Conclusions
Available data do not support a role for oncogenic HPV in the development of the majority of skin cancers, either in the general population or in organ-transplant recipients. The exception to this may be peri-ungual squamous cell carcinomas where HPV 16 and 18 are consistently identified. It is possible that infection with benign HPV types may be a co-factor in the development of some cutaneous squamous cell cancers, particularly in transplant recipients, but this needs further investigation.
A role for HPV types 5 and 8 in the development of skin cancer in patients with EV seems more probable, although the mechanism by which these oncogenic papillomaviruses transform keratinocytes is not currently known.
